Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Effect of Physical Conditions on the Transportation of Peripheral Blood Progenitor (PBPC) Products.

Jan Jansen, MD, PhD., Pamela L Nolan, MT(ASCP), Margaret I Reeves, BS, Luke Paul Akard, MD, James M. Thompson, DO, Michael J Dugan, MD, Susan G Hanks, MS

Blood (2008) 112 (11): 2315.

https://doi.org/10.1182/blood.V112.11.2315.2315

Published: 2008

Journal Articles

Phase II Trial of Prochymal™ (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) and Corticosteroids as Primary Treatment for Acute Graft-Vs-Host Disease (aGVHD).

Partow Kebriaei, MD, Luis Isola, MD, Erkut Bahceci, MD, H. Kent Holland, MD, Scott Rowley, MD, Joseph McGuirk, DO, Marcel Devetten, MD, Jan Jansen, MD, PhD, Roger Herzig, MD, Michael Schuster, MD, Joseph Uberti, MD, PhD

Blood (2006) 108 (11): 3231.

https://doi.org/10.1182/blood.V108.11.3231.3231

Published: 2006

Journal Articles

Influence of Comorbidities on Outcomes of Autologous and Allogeneic Stem Cell Transplantation (SCT).

Kerry M. Fitzpatrick, BA, Luke Paul Akard, MD, Michael Dugan, MD, James M. Thompsom, DO, Colin L. Terry, MS, Jan Jansen, MD, PhD

Blood (2005) 106 (11): 1327.

https://doi.org/10.1182/blood.V106.11.1327.1327

Published: 2005

Journal Articles

What Is the Most Useful Information Provided to Stem Cell Transplant Recipients?.

Kerry M. Fitzpatrick, BA, Luke Paul Akard, MD, Michael Dugan, MD, Jan Jansen, MD, PhD, James M. Thompson, DO, Amy Fredericks, LMSW

Blood (2005) 106 (11): 3129.

https://doi.org/10.1182/blood.V106.11.3129.3129

Published: 2005

Journal Articles

Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.

Michael J. Dugan, MD, Luke P. Akard, MD, James M. Thompson, DO, Auayporn Nademanee, MD, Richard T. Maziarz, MD, William I. Bensinger, MD, Jane Liesveld, MD, Karin Badel, Christine Dehner, Colleen Gibney, Gary Calandra, Jan Jansen, MD, PhD

Blood (2004) 104 (11): 2860.

https://doi.org/10.1182/blood.V104.11.2860.2860

Published: 2004

NARROW

The Effect of Physical Conditions on the Transportation of Peripheral Blood Progenitor (PBPC) Products.

Phase II Trial of Prochymal™ (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) and Corticosteroids as Primary Treatment for Acute Graft-Vs-Host Disease (aGVHD).

Influence of Comorbidities on Outcomes of Autologous and Allogeneic Stem Cell Transplantation (SCT).

What Is the Most Useful Information Provided to Stem Cell Transplant Recipients?.

Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.

Email alerts

ASH Publications

American Society of Hematology

The Effect of Physical Conditions on the Transportation of Peripheral Blood Progenitor (PBPC) Products.

Phase II Trial of Prochymal™ (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) and Corticosteroids as Primary Treatment for Acute Graft-Vs-Host Disease (aGVHD).

Influence of Comorbidities on Outcomes of Autologous and Allogeneic Stem Cell Transplantation (SCT).

What Is the Most Useful Information Provided to Stem Cell Transplant Recipients?.

Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only